Watchlist for December 20, 2006

Image courtesy of Stan Yan’s Tickle Tape

I have nothing to say this morning. ? Good trading to you…

On Today’s Calendar:

10:30 — Crude Inventories

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

NFLD -48% (disappointing clinical trial data for blood substitute), PANC -36% (disappointing clinical trial data for Bevirimat), SBH -17% (loses exclusive distribution rights with L’Oreal, also downgrades from Pru and OpCo), FOXH -14% (guides lower), GBX -13% (guides NovQ below expectations), TRAC -8.4% (extends recent weakness), FSII -6.1% (reports NovQ, beats by $0.03, but light on revs, guides FebQ revs lower), GMXR -5.6% (provides operational update), DRYS -5.5%, FDX -3% (reports NovQ, beats by $0.13, but guides FebQ below consensus), EXAR -2.9% (lowers rev guidance), CBK -2.2% (reports Q3, guides Q4 below consensus), JNPR -1.5% (CIBC downgrade), TSM -1.2% (extends recent weakness)… Under $3: VXGN.PK -22% (says US cancels anthrax contract), GNVC -16% (announces stock offering).

Gapping Up

ENCO +24% (announces contract With major pharma co for a phase 3 trial), RBAK +18% (to be acquired by ERIC +1%), MDTL +16% (successful UL test), ICOS +15% (co accepts LLY’s sweetened takeover offer – WSJ), KOSN +12% (signs stomach drug pact with Pfizer), SYX +12% (reports Q3), ALTU +11% (announces collaboration with Genentech), ESCL +13% (extends yesterday’s 92% move), KMX +7.7% (reports NovQ), EVST +7.6% (up on CNBC segment that it’s a play on Rocky movie), FFHL +7.5% (extends yesterday’s big move on IPO debut), RPRX +6.5% (positive phase 3 data), EDA +6.1% (extends yesterday’s 15% move), SMOD +4.7% (reports NovQ), NBIX +4.7% (initiates clinial trial, receives milestone payment), NHWK +4.6% (Morgan Stanley upgrade), INWK +4.4% (Cramer bullish on Mad Money, says stock has a long way to run, see our recent profile), CMED +4.7% (successfully develops reagents), GMST +4% (extends yesterday’s 13% move), KF +3.9% (fund announces distribution), MAMA +3.3% (extends momentum, +140% in a week or so), SYMC +2.2% (Goldman upgrade), UMC +1.5% (files Form 6-K), PAY +1.4% (Cramer bullish on Mad Money, he sees a big upgrade cycle coming; also see our recent Small Cap Focus), HNZ +1%, PALM +0.5% (reports NovQ, beats by $0.02, but guides below consensus)